NGM Biopharmaceuticals (NGM) Stock Analysis
DELISTED 2024
What happened to NGM Biopharmaceuticals (NGM) stock?
NGM Biopharmaceuticals (NGM) no longer trades on public markets. It was delisted in April 2024. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- April 2024
- Last recorded price (historical):
- $1.54 (last quote on record before the April 2024 delisting; historical, not a current quote)
Market cap $129M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
NGM Biopharmaceuticals (NGM). NGM Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapeutics for liver, metabolic, and retinal diseases, as well as cancer.
Last analyzed: May 10, 2026NGM Biopharmaceuticals (NGM) Healthcare & Pipeline Overview
More about this archive record
Can I still buy NGM shares?
No. NGM stopped trading on public markets in April 2024, so the shares are not available through a broker. Anything you see quoted for NGM elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before NGM stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to NGM Biopharmaceuticals. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.